ATAI - CIK 0001840904
ATAI Life Sciences N.V. (ATAI) reported net income of -$149.27M for fiscal year 2024, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2024 | -$149.27M | -271.1% |
| FY 2023 | -$40.22M | +73.6% |
| FY 2022 | -$152.38M | +9.2% |
| FY 2021 | -$167.81M | +1.2% |
| FY 2020 | -$169.84M | - |
ATAI Life Sciences N.V. (ATAI) reported net income of -$149.27M for fiscal year 2024, as filed in its audited annual report with the SEC.
Between fiscal 2020 and fiscal 2024, ATAI Life Sciences N.V.'s net income grew from -$169.84M to -$149.27M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.